EFFIMUNE SAS
Effimune SA, a biotechnology company, engages in the discovery and development of therapeutic molecules, antibodies, and therapies for auto-immune diseases and transplantation. It specializes in the research and development of immunomodulators in autoimmunity and transplantation. The company’s solutions include FR104, a monovalent pegylated Fab antibody antagonist of the CD28 that blocks effector T cell responses and amplifies Treg responses; MD707, a monoclonal antibody that depletes effector... T lymphocytes without altering Treg; and MP196, a monoclonal antibody that specifically neutralizes IL-23, a cytokine implied in various auto-immune diseases, such as rheumatoid arthritis, Crohn’s disease, and multiple sclerosis. Its drugs regulate the immune system in organ and tissue transplantation, and auto-immune disease.
EFFIMUNE SAS
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Nantes, Pays De La Loire, France
Country:
France
Website Url:
http://www.effimune.com
Total Employee:
11+
Status:
Active
Contact:
+33240412834
Email Addresses:
[email protected]
Technology used in webpage:
SPF OVH OVH DNS OVH Mail
Current Employees Featured
Official Site Inspections
http://www.effimune.com
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
